Zusammenfassung
Hintergrund
Eine interdisziplinäre Leitlinie auf Entwicklungsstufe S3 der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF – systematische Literatursuche und -bewertung, Logikanalyse, formaler Konsensusprozess) zu Definition, Klassifikation, Diagnose, Verlauf und Prognose chronischer Schmerzen in mehreren Körperregionen („chronic widespread pain“, CWP) und des Fibromyalgiesyndroms (FMS) wurde in Kooperation von 10 medizinischen bzw. psychologischen Fachgesellschaften und 2 Patientenselbsthilfeorganisationen erstellt.
Methodik
Eine Literatursuche wurde unter Benutzung der Cochrane Library (1993–12/2006), Medline (1980–2006), PsychInfo (1966–12/2006) und Scopus (1980–12/2006) durchgeführt. Für die Vergabe von Evidenzklassen wurde das System des Oxford Centre for Evidence-Based Medicine herangezogen. Für die Vergabe von Empfehlungsgraden wurde die Empfehlungsgraduierung der nationalen Versorgungsleitlinien verwendet. Die Erstellung der Empfehlungen erfolgte in einem mehrstufigen nominalen Gruppenprozess.
Ergebnisse
Chronische Schmerzen in mehreren Körperregionen werden durch die Kriterien des Amerikanischen Kollegiums für Rheumatologie definiert (ACR – starker Konsens). Die klinische Diagnose des FMS kann sowohl symptombasiert (ohne klinische Untersuchung von Tenderpoints) als auch nach den ACR-Kriterien erfolgen (starker Konsens).
Abstract
Background
Interdisciplinary guidelines for the definition, classification and diagnosis of chronic widespread pain (CWP) and fibromyalgia syndrome (FMS) were developed by collaboration of 10 German medical and psychological associations and 2 patient self-help organizations.
Methods
A systematic literature search was performed in the Cochrane Library (1993–12/2006), Medline (1980–2006), PsychInfo (1966–12/2006), and Scopus (1980–12/2006). Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. Grading of the strength of recommendation was done according to the German program for disease management guidelines. Standardized procedures to reach a consensus on recommendations were used.
Results
CWP is defined by the criteria of the American College of Rheumatology (ACR – strong consensus). FMS can be diagnosed for clinical purposes by symptom-based criteria (without tender point examination) as well as by the ACR criteria (strong consensus).
Literatur
Aaron LA, Bradley LA, Alarcon GS et al. (1996) Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 39: 436–445
Aaron LA, Bradley LA, Alarcon GS et al. (1997) Perceived physical and emotional trauma as precipitating events in fibromyalgia. Associations with health care seeking and disability status but not pain severity. Arthritis Rheum 40: 453–460
Aaron L, Buchwald D (2003) Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol 17: 563–574
Aaron LA, Buchwald D (2001) Fibromyalgia and other unexplained clinical conditions. Curr Rheumatol Rep 3: 116–121
Al-Allaf AW, Ottewell L, Pullar T (2002) The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2–4 years‘ follow-up. Clin Rheumatol 21: 472–477
Alexander RW, Bradley LA, Alarcon GS et al. (1998) Sexual and physical abuse in women with fibromyalgia: association with outpatient health care utilization and pain medication usage. Arthritis Care Res 11: 102–115
Andersson HI, Ejlertsson G, Leden I, Rosenberg C (1996) Characteristics of subjects with chronic pain, in relation to local and widespread pain report. A prospective study of symptoms, clinical findings and blood tests in subgroups of a geographically defined population. Scand J Rheumatol 25: 146–154
Baumgartner E, Finckh A, Cedraschi C, Vischer TL (2002) A six year prospective study of a cohort of patients with fibromyalgia. Ann Rheum Dis 61: 644–645
Bengtsson A, Backman E, Lindblom B, Skogh T (1994) Long term follow-up of fibromyalgia patients: Clinical symptoms, muscular function, laboratory tests – an eight year comparison study. J Musculoskeletal Pain 2: 67–80
Bergman S, Herrstrom P, Jacobsson LT, Petersson IF (2002) Chronic widespread pain: a three year followup of pain distribution and risk factors. J Rheumatol 29: 818–825
Bernatsky S, Dobkin PL, De Civita M, Penrod JR (2005) Co-morbidity and physician use in fibromyalgia. Swiss Med Wkly 135: 76–81
Biewer W, Conrad I, Häuser W (2004) Fibromyalgiesyndrom. Schmerz 18: 118–124
Boonen A, van den Heuvel R, van Tubergen A et al. (2005) Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 64: 396–402
Burckhardt CS, Goldenberg D, Crofford L et al. (2005) Guideline for the management of fibromyalgia syndrome pain in adults and children. APS Clinical Practice Guidelines Series No 4. American Pain Society, Glenview
Clauw D, Crofford LJ (2003) Chronic widespread pain and fibromyalgia: what we know and what we need to know. Best Pract Res Clin Rheumatol 17: 685–701
Croft P, Rigby AS, Boswell R et al. (1993) The prevalence of chronic widespread pain in the general population. J Rheumatol 20: 710–713
Croft PR, Schollurn J, Süman AJ (1994) Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 309: 696–699
Croft PR, Burt J, Schollum J (1996) More pain, more tender points: is fibromyalgia just one end of a continuous spectrum? Ann Rheum Dis 55: 482–485
Deutsches Institut für medizinische Dokumentation und Information (DIMDI) (2006) ICD 10-GM. Version 2006. Internationale Statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision – German modification. http://www.dimdi.de/static/de/klassi/diagnosen/icd10/index.htm
Dobkin PL, De Civita M, Bernatsky S et al. (2003) Does psychological vulnerability determine health-care utilization in fibromyalgia? Rheumatology (Oxford) 42: 1324–1331
Dobkin PL, De Civita M, Abrahamowicz M et al. (2006) Predictors of health status in women with fibromyalgia: a prospective study. Int J Behav Med 13: 101–108
Donner-Banzhoff N, Maisel P, Baum E, Dörr C (2005) DEGMA-Leitlinie 2: Müdigkeit. http://www.degam.de/leitlinien/LL_muede_netz.pdf
Doron Y, Peleg R, Peleg A et al. (2004) The clinical and economic burden of fibromyalgia compared with diabetes mellitus and hypertension among Bedouin women in the Negev. Fam Pract 21: 415–419
Evers S, Göbel H (2003) Die deutschsprachige Übersetzung der 2. Auflage der Kopfschmerzklassifikation der International Headache Society. Nervenheilkunde 22: 531–670
Felson DT, Goldenberg DL (1986) The natural history of fibromyalgia. Arthritis Rheum 29: 1522–1526
Forseth KO, Forre O, Gran JT (1999a) A 5.5 year prospective study of self-reported musculoskeletal pain and of fibromyalgia in a female population: significance and natural history. Clin Rheumatol 18: 114–121
Forseth KO, Husby G, Gran JT, Forre O (1999b) Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study. J Rheumatol 26: 2458–2467
Gran JT (2003) The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17: 547–561
Gralow I (2004) Ist die Fibromyalgie eine Krankheit? – Contra. Dtsch Med Wochenschr 129: 1337
Granges G, Zilko P, Littlejohn GO (1994) Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis. J Rheumatol 21: 523–529
Hagen KB, Bjørndal A, Uhlig T, Kvien TK (2000) A population study of factors associated with general practitioner consultation for non-inflammatory musculoskeletal pain. Ann Rheum Dis 59: 788–793
Harth M, Nieslon RW (2007) The fibromyalgia tender points: use them or lose them? A brief review of the controversy. J Rheumatol 34: 914–922
Häuser W, Türp JC, Lempa M et al. (2004) Funktionelle somatische Schmerzsyndrome – Nomenklatur. Schmerz 18: 98–103
Häuser W (2005) Fibromyalgia in the legal procedures of the german sozialgericht – psychosocial risk factors and predictors of health care utilization. Psychother Psychosom Med Psychol 55: 72–78
Häuser W, Bernardy K, Arnold B (2006a) Das Fibromyalgiesyndrom – eine somatoforme Schmerzstörung? Schmerz 20: 128–139
Häuser W, Wilhelm R, Klein W, Zimmer C (2006b) Causal illness attributions and healthcare utilization in fibromyalgia syndrome. Schmerz 20: 119–127
Häuser W, Musial F, Kopp I, Bernardy K (2008) Methodische Grundlagen für die Entwicklung der Leitlinienempfehlungen (Methodenreport). Schmerz 22, im Druck
Hawley DJ, Wolfe F, Cathey MA (1988) Pain, functional disability, and psychological status: a 12-month study of severity in fibromyalgia. J Rheumatol 15: 1551–1556
Henningsen P, Zimmermann T, Sattel H (2003) Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 65: 528–533
Henningsen P, Derra C, Turp JC, Häuser W (2004) Functional somatic pain syndromes: summary of hypotheses of their overlap and etiology. Schmerz 18: 136–140
Henningsen P, Zipfel S, Herzog W (2007) Management of functional somatic syndromes. Lancet 369: 946–955
Henriksson CM, Lindberg GM, Gerdle B (2005) Women with fibromyalgia: work and rehabilitation. Disabil Rehabil 27: 685–695
Hiller W, Rief W, Brahler E (2006) Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 41: 704–712
Hueppe A, Brockow T, Raspe H (2004) Chronic widespread pain and tender points in low back pain: a population-based study. Z Rheumatol 63: 76–83
Hughes G, Martinez C, Myon E et al. (2006) The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 54: 177–183
Jaeckel WH, Traber U, Gerdes N (2004) Stationäre Rehabilitation bei Fibromyalgie-Patientlnnen: Konzept und Ergebnisse. Akt Rheumatol 29: 270–275
Kato K, Sullivan PF, Evengard B, Pedersen NL (2006) Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 166: 1649–1654
Katz RS, Wolfe F, Michaud K (2006) Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 54: 169–176
Kennedy M, Felson DT (1996) A prospective long-term study of fibromyalgia syndrome. Arthritis Rheum 39: 682–685
Kersh BC, Bradley LA, Alarcon GS et al. (2001) Psychosocial and health status variables independently predict health care seeking in fibromyalgia. Arthritis Rheum 45: 362–371
Kivimäki M, Leino-Arjas P, Kaila-Kangas L et al. (2007) Increased sickness absence among employees with fibromyalgia. Ann Rheum Dis 66: 65–69
Kohlmann T (2003) Muskuloskelettale Schmerzen in der Bevölkerung. Schmerz 17: 405–411
Kroenke K, Mangelsdorff AD (1989) Common symptoms in ambulatory care: incidence, evaluation, therapy and outcome. Am J Med 82: 262
Kroenke K, Rosmalen JG (2006a) Symptoms, syndromes, and the value of psychiatric diagnostics in patients who have functional somatic disorders. Med Clin North Am 90: 603–626
Kroenke K (2006b) Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 60: 335–339
Lappossy E, Maleitzke E, Hrycai P et al. (1993) Der Langzeitverlauf der generalisierten Tendomyopathie (Fibromyalgie), eine retrospective Unrersuchung. Akt Rheumatol 18: 93–98
Ledingham J, Doherty S, Doherty M (1993) Primary fibromyalgia syndrome–an outcome study. Br J Rheumatol 32: 139–142
Lindgren H, Bergman S (2005) The use and diagnostic yield of radiology in subjects with longstanding musculoskeletal pain – an eight year follow up. BMC Musculoskeletal Disord 6: 53
Longstreth GF, Thompson WG, Chey WD et al. (2006) Functional bowel disorders. Gastroenterology 130: 1480–1491
Lundberg G, Gerdle B (2002) Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of fibromyalgia syndrome. J Rheumatol 29: 603–613
MacFarlane GJ, Thomas E, Papageorgiou AC et al. (1996) The natural history of chronic pain in the community: a better prognosis than in the clinic? J Rheumatol 23: 1617–1620
Mease PJ, Clauw DJ, Arnold LM et al. (2005) Fibromyalgia syndrome. J Rheumatol 32: 2270–2277
McBeth J, Macfarlane GJ, Benjamin S et al. (1999) The association between tender points, psychological distress, and adverse childhood experiences: a community based study. Arthritis Rheum 42: 1397–1404
Merskey H, Bogduk N (1994) Classification of chronic pain. IASP Press, Seattle
Müller A, Hartmann M, Eich W (2000) Health care utilization in patients with fibromyalgia syndrome (FMS). Schmerz 14: 77–83
Müller W, Stratz T (2004) Ist die Fibromyalgie eine Krankheit? – Pro. Dtsch Med Wochenschr 129: 1336
Nicassio PM, Weisman MH, Schuman C, Young CW (2000) The role of generalized pain and pain behavior in tender point scores in fibromyalgia. J Rheumatol 27: 1056–1062
Nöller V, Sprott H (2003) Prospective epidemiological observations on the course of the disease in fibromyalgia patients. J Negat Results Biomed 23: 4
Pamuk ON, Yethil Y, Cakir N (2006) Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain? Semin Arthritis Rheum 36: 130–134
Papageorgiou AC, Silman AJ, Macfarlane GJ (2002) Chronic widespread pain in the population: a seven year follow up study. Ann Rheum Dis 61: 1071–1074
Petzke F, Gracely RH, Park KM et al. (2003) What do tender points measure? Influence of distress on 4 measures of tenderness. J Rheumatol 30: 567–574
Poyhia R, Da Costa D, Fitzcharles MA (2001) Pain and pain relief in fibromyalgia patients followed for three years. Arthritis Rheum 45: 355–361
Raphael KG, Janal MN, Nayak S et al. (Jahreszahl fehlt) Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain 110: 449–460
Raymond MC, Brown JB (2000) Experience of fibromyalgia. Qualitative study. Can Fam Physician 46: 1100–1106
Resine S, Fifield J, Walsh S, Dauser D (2004) Employment and quality of life outcomes among women with fibromyalgia compared to healthy controls. Women Health 39: 1–19
Rief W, Isaac M (2007) Are somatoform disorders „mental disorders“? A contribution to the current debate. Curr Opin Psychiatry 20: 143–146
Robinson RL, Birnbaum HG, Morley MA et al. (2004) Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently. J Rheumatol 31: 1621–1629
Ruiz Moral R, Munoz Alamo M, Perula de Torres L, Aguayo Galeote M (1997) Biopsychosocial features of patients with widespread chronic musculoskeletal pain in family medicine clinics. Fam Pract 14: 242–248
Schochat T, Raspe H (2003) Elements of fibromyalgia in an open population. Rheumatology (Oxford) 42: 829–835
Suarez-Almazor ME, Gonzalez-Lopez L, Gamez-Nava JI et al. (1998) Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians. J Rheumatol 25: 1980–1985
Thieme K, Turk DC, Flor H (2004) Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 66: 837–844
Topbas M, Cakirbay H, Gulec H et al. (2005) The prevalence of fibromyalgia in women aged 20–64 in Turkey. Scand J Rheumatol 34: 140–144
Tunks E, McCain GA, Hart LE et al. (1995) The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls. J Rheumatol 22: 944–952
Turk DC, Flor H (1989) Primary fibromyalgia is greater than tender points: toward a multiaxial taxonomy. J Rheumatol 19 [suppl]: 80–86
Walen HR, Cronan PA, Bigatti SM (2001) Factors associated with healthcare costs in women with fibromyalgia. Am J Manag Care 25: SP39–SP47
Walen H, Cronan T, Serber E et al. (2002) Subgroups of fibromyalgia patients: evidence for heterogeneity and an examination of differential effects following a community-based intervention. J Musculoskeletal Pain 10: 9–32
Weir PT, Harlan GA, Nkoy FL et al. (2006) The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th revision codes. J Clin Rheumatol 12: 124–128
Wessely S, Nimnuan C, Sharpe M (1999) Functional somatic syndromes: one or many? Lancet 354: 936–939
White KP, Speechley M, Harth M, Ostbye T (1999) Comparing self-reported function and work disability in 100 community cases of fibromyalgia snydrom versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis Rheum 42: 76–83
White KP, Harth M, Speechley M, Ostbye T (2000) A general population study of fibromyalgia tender points in noninstitutionalized adults with chronic widespread pain. J Rheumatol 27: 2677–2682
White KP, Nielson WR, Harth M et al. (2002a) Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 29: 588–594
White KP, Nielson WR, Harth M et al. (2002b) Does the label „fibromyalgia“ alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis Rheum 15(47): 260–265
Wigers H (1994) Fibromyalgia outcome: the predictive values of symptom duration, physical activity, disability pension, and critical life events–a 4.5 year prospective study. J Psychosom Res 41: 235–243
Wolfe F, Srnythe HA, Yunus MB et al. (1990) The American College of Rheumatology 1 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33: 160–172
Wolfe F (1997a) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56: 268–271
Wolfe F, Anderson J, Harkness D et al. (1997b) A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 40: 1560–1570
Wolfe F (1998) What use are fibromyalgia control points? J Rheumatol 25: 546–550
Wolfe F (2003) Stop using the American College of Rheumatology criteria in the clinic. J Rheumatol 30: 1671–1672
Zonana-Nacach A, Alarcón GS, Reveille JD et al. (1998) Clinical features of ANA-positive and ANA-negative patients with fibromyalgia. J Clin Rheumatol 4: 52–56
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehungen hin: Fa. Pfizer (Vortragshonorar), Fa. Ergonex, Schweiz (Multicenter-RCT, Pharmastudie).
Author information
Authors and Affiliations
Corresponding author
Additional information
Die Mitgliedschaften der Autoren in Fachgesellschaften sind in Infobox 1 aufgelistet.
Rights and permissions
About this article
Cite this article
Eich, W., Häuser, W., Friedel, E. et al. Definition, Klassifikation und Diagnose des Fibromyalgiesyndroms. Schmerz 22, 255–266 (2008). https://doi.org/10.1007/s00482-008-0671-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00482-008-0671-7
Schlüsselwörter
- Chronische Schmerzen in mehreren Körperregionen
- Fibromyalgiesyndrom (FMS)
- Definition
- Klassifikation
- Diagnose
- Leitlinie